SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001720725-19-000010
Filing Date
2019-12-03
Accepted
2019-12-03 07:17:57
Documents
3
Period of Report
2019-12-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kcover.htm 8-K 33866
2 EX-99.1 oystearningspressrelea.htm EX-99..1 89619
3 image01.jpg GRAPHIC 31484
  Complete submission text file 0001720725-19-000010.txt   168126
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39112 | Film No.: 191264624
SIC: 2836 Biological Products, (No Diagnostic Substances)